Skip to main content

Table 1 Overview of the type and timing of measurements

From: A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design

Measurement Specification ROM Screening T0 T1 T2 T3 T4 FU
PCL-5 PTSD symptoms X        
SCID-5-PD screener PD symptoms X        
OQ-45 Psychiatric symptoms X   X X X X X X
SCID-5-S Axis I-disorders   X      X  
SCID-5-PD PD   X X     X  
CAPS-5 PTSD    X   X   X  
Demographic questionnaire Demographics    X      
STAS NL Anger    X   X   X  
DERS NL Emotion regulation    X   X   X  
PAI-BOR BPD symptoms    X   X    X
NSSI Non-suicidal self-injury    X X X X X X
WHODAS 2.0 General functioning    X   X   X X
EQ-5D-5 L Quality of life    X   X   X X
TiC-P Health care consumption    X   X   X X
Height/weight     X      
Blood pressure Systolic and diastolic    X      
Hair sample HPA-axis (cortisol)    X   X    
BDNF Protein and methylation    X   X    
FKBP5 Protein and methylation    X   X    
  1. BDNF Brain-derived neurotrophic factor, CAPS-5 = Clinician-Administered PTSD scale for DSM-5, DERS NL Difficulties in Emotion RegulationScale - Dutch version, FKBP5 FK506-binding protein, NSSI= Non Suicidal Self-Injury screener, OQ-45 Outcome Questionnaire, PAI-BOR Personality Assessment Inventory - Borderline features scale, PCL-5 PTSD Checklist for DSM-5, ROM Routine Outcome Measurement, SCID-5-PD Structured Clinical Interview for DSM-5 Personality disorders, SCID-5-S Structured Clinical Interview for DSM-5 Syndrome Disorders; STAS NL State-Trait Anger Scale – Dutch version; TiC-P Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness, WHODAS WorldHealth Organization Disability Assessment Schedule 2.0